Financhill
Sell
18

HEAL Quote, Financials, Valuation and Earnings

Last price:
$25.28
Seasonality move :
-8.62%
Day range:
$25.16 - $26.16
52-week range:
$24.48 - $35.73
Dividend yield:
0.38%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
25.1K
Avg. volume:
15.1K
1-year change:
-24%
Market cap:
--
Revenue:
--
EPS (TTM):
--

Analysts' Opinion

  • Consensus Rating
    No consensus rating exists at this time due to lack of analyst coverage.
  • Price Target Downside
    No price target exists because of limited analyst coverage.
  • Price Target Upside
    Similarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.

Fair Value

  • According to the consensus of 0 analysts, Global X HealthTech ETF has -- downside to fair value with a price target of -- per share.

HEAL vs. S&P 500

  • Over the past 5 trading days, Global X HealthTech ETF has underperformed the S&P 500 by -2.92% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Global X HealthTech ETF does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Global X HealthTech ETF has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Global X HealthTech ETF reported revenues of --.

Earnings Growth

  • Global X HealthTech ETF has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Global X HealthTech ETF reported earnings per share of --.
Enterprise value:
--
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
Trailing 12 Months Fiscal Quarters
Period Ending 2024-02-13 2025-02-13 2025-02-13
Income Statement
Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
Operating Income -- -- -- -- --
EBITDA -- -- -- -- --
Diluted EPS -- -- -- -- --
Period Ending 2022-02-13 2023-02-13 2024-02-13 2025-02-13
Balance Sheet
Current Assets -- -- -- -- --
Total Assets -- -- -- -- --
Current Liabilities -- -- -- -- --
Total Liabilities -- -- -- -- --
Total Equity -- -- -- -- --
Total Debt -- -- -- -- --
Trailing 12 Months Fiscal Quarters
Period Ending 2024-02-13 2025-02-13 2025-02-13
Cash Flow Statement
Cash Flow Operations -- -- -- -- --
Cash From Investing -- -- -- -- --
Cash From Financing -- -- -- -- --
Free Cash Flow -- -- -- -- --
HEAL
Sector
Market Cap
--
--
Price % of 52-Week High
70.45%
--
Dividend Yield
0.38%
--
Shareholder Yield
--
--
1-Year Price Total Return
-24%
--
Beta (5-Year)
1.232
--
Dividend yield:
0.38%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $26.50
200-day SMA
Sell
Level $31.09
Bollinger Bands (100)
Sell
Level 28.98 - 32.4
Chaikin Money Flow
Sell
Level -42.2K
20-day SMA
Sell
Level $28.42
Relative Strength Index (RSI14)
Sell
Level 18.81
ADX Line
Sell
Level 47.76
Williams %R
Buy
Level -99.7062
50-day SMA
Sell
Level $29.66
MACD (12, 26)
Buy
Level 7.02
25-day Aroon Oscillator
Sell
Level -96
On Balance Volume
Sell
Level -145K

Financial Scores

--
Altman Z-Score (Annual)
Level (--)
--
CA Score (Annual)
Level (--)
--
Beneish M-Score (Annual)
Level (--)
Buy
Momentum Score
Level (5)
--
Ohlson Score
Level (--)
--
Piotroski F Score (Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)

Revenue Forecast

Earnings per Share Forecast

Stock Forecast FAQ

In the current month, HEAL has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The HEAL average analyst price target in the past 3 months is --.

  • Where Will Global X HealthTech ETF Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Global X HealthTech ETF share price will drop to -- per share over the next 12 months.

  • What Do Analysts Say About Global X HealthTech ETF?

    Analysts are divided on their view about Global X HealthTech ETF share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Global X HealthTech ETF is a Sell and believe this share price will rise from its current level to --.

  • What Is Global X HealthTech ETF's Price Target?

    The price target for Global X HealthTech ETF over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is HEAL A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Global X HealthTech ETF is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of HEAL?

    You can purchase shares of Global X HealthTech ETF via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Global X HealthTech ETF shares.

  • What Is The Global X HealthTech ETF Share Price Today?

    Global X HealthTech ETF was last trading at $25.28 per share. This represents the most recent stock quote for Global X HealthTech ETF. Yesterday, Global X HealthTech ETF closed at $25.17 per share.

  • How To Buy Global X HealthTech ETF Stock Online?

    In order to purchase Global X HealthTech ETF stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will UnitedHealth Stock Recover?
Will UnitedHealth Stock Recover?

Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…

Is Lumentum The Best Laser Stock to Buy?
Is Lumentum The Best Laser Stock to Buy?

Though certainly less well-known than the huge tech businesses that…

Is Planet Fitness Stock Undervalued?
Is Planet Fitness Stock Undervalued?

Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…

Stock Ideas

Buy
54
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 64x

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 35x

Sell
42
Is GOOG Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 29x

Alerts

Sell
17
ICLR alert for Feb 13

ICON plc [ICLR] is up 16.17% over the past day.

Buy
67
CGNX alert for Feb 13

Cognex Corp. [CGNX] is up 0.29% over the past day.

Buy
77
IPGP alert for Feb 13

IPG Photonics Corp. [IPGP] is up 1.16% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock